InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In

InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since 2021, INMD's robust balance sheet, strong FCF generation, and signs of improving fundamentals support a reiterated strong buy rating. Operational challenges—declining margins, inventory build, and sales execution—are offset by aggressive buybacks, high FCF yield, and significant upside if management improves capital allocation.

Seeking Alpha • Dec 11, 2025

InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript

InMode Ltd. ( INMD ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Miri Segal-Scharia - MS-IR LLC Danielle Antalffy - UBS Investment Bank, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Presentation Operator Good day, and welcome to InMode's Third Quarter 2025 Earnings Results Conference Call.

Seeking Alpha • Nov 5, 2025

InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025.

PRNewsWire • Nov 5, 2025

InMode Appoints Michael Dennison as President of North America

IRVINE, Calif. , Nov. 3, 2025 /PRNewswire/ -- InMode Ltd.

PRNewsWire • Nov 3, 2025

InMode to Participate in Upcoming Investor Conferences

YOKNEAM, Israel , Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November: UBS Global Healthcare Conference Presenter: Yair Malca, Chief Financial Officer Format: In-person one-on-one meetings Location: Palm Beach Gardens, FL When: Monday, November 10 Jefferies Global Healthcare Conference Presenter: Moshe Mizrahy, Chief Executive Officer Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings Location: London, U.K. When: Tuesday, November 18, Fireside Chat at 4:00 pm GMT A live webcast of the presentation can be accessed here.

PRNewsWire • Oct 30, 2025

InMode: Discounted Valuation & Strong Fundamentals Make It A Buy

InMode presents an appealing buy opportunity, trading near 52-week lows with strong fundamentals, innovative technology, and global expansion. INMD's minimally invasive platforms drive revenue growth, with international markets and new product launches supporting diversification and future potential. Despite regulatory, tariff, and demand risks, INMD maintains robust margins, a strong cash position, and disciplined cost control, ensuring operational resilience.

Seeking Alpha • Oct 27, 2025

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M

Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd.

PRNewsWire • Oct 9, 2025

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders

Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026 Maintains Board Has Legal and Fiduciary Duty to Act in Best Interests of Shareholders  MIAMI , Sept. 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd.

PRNewsWire • Sep 9, 2025

InMode to Present at Baird 2025 Global Healthcare Conference

YOKNEAM, Israel , Sept. 2, 2025 /PRNewswire/ --  InMode Ltd.

PRNewsWire • Sep 2, 2025

InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript

InMode Ltd. (NASDAQ:INMD ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Danielle Joy Antalffy - UBS Investment Bank, Research Division Jeffrey D.

Seeking Alpha • Jul 30, 2025